Founder , Chairman , Chief Executive Officer
Dr. Zaiqi Wang,is a founder of our Group. He was appointed as a Director and our chief executive officer on November 29, 2018. He is primarily responsible for the overall strategic planning and making key business and operational decisions of the Group. Dr. Zaiqi has extensive experience in pharmaceutical research and development, clinical development, and corporate management within the global biopharmaceutical industry. Dr.Wang served as a resident in internal medicine at Union Memorial Hospital in the United States from June 1995 to June 1998. Subsequently, Dr. Zaiqi held the position of director of clinical research and experimental medicine at Schering-Plough Corporation (currently known as Merck & Co., Inc.), a pharmaceutical company formerly listed on the New York Stock Exchange (stock code: SGP), in the United States from January 2001 to March 2009. From April 2009 to June 2011, he was the director of clinical research in the Translational Medicine Center (Singapore) of Merck & Co., Inc., a New York Stock Exchange-listed company (stock code: MRK), and he subsequently served in Merck & Co., Inc. (China) with his last position as head of clinical research from June 2011 to November 2017. Prior to co-founding our Group,Dr. Zaiqi served as the head of the R&D innovation center at the Shanghai Innovation Center of Roche China from December 2017 to December 2018.Dr. Zaiqi served as the vice chair of the DIA Drug Discovery Innovation (DDI)Conference in 2018 and as chair in 2019. He is an editorial board member of Clinical and Translational Research. Dr. Zaiqi obtained the medical license for clinical pharmacology in 2001 and the medical license for internal medicine in 2008. In August 2020, Dr. Zaiqi was recognized as a “Jiangbei New Area High-level Entrepreneurial Talent” . Dr. Zaiqi received his bachelor’s degree in medicine from Henan Medical College of Zhengzhou University in the PRC in August 1983. He obtained his doctor’s degree from Virginia Polytechnic Institute and State University in the United States in August 1992. He also finished his post-doctoral research in Johns Hopkins School of Medicine in the United States in June 1995.
Latest Products